The Washington Times/ABC News investigative report into the VA’s smoking cessation research program involving Chantix, has caused some serious questioning of VA accountability. Chantix has been linked to almost 40 suicides and more than 400 incidents of suicidal behavior. The drug's manufacturer and the FDA have recently cautioned healthcare providers about adverse side effects that could produce changes in behavior ranging from anxiety and depression to suicide. So, why was the drug given to 143 veterans suffering from PTSD? Who better to ask than VA's Chief of Research and Development, Joel Kupersmith? We'll sit down with him for some hard-hitting questions, and hopefully, some answers.
HOT TOPICS: Scammers prey on troops' families! l Veterans wants Iraq duty to count toward jail term! l Gen. Lynch requires soldiers to take motorcycle refresher course!

plus-circle Add Review

comment

Reviews